ALPHA TEKNOVA, INC. Repayments of Long-Term Debt
ALPHA TEKNOVA, INC. (TKNO) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-03-07
- ALPHA TEKNOVA, INC. repayments of long-term debt for the quarter ending 2024-12-31 was $0.00.
- ALPHA TEKNOVA, INC. repayments of long-term debt for the quarter ending 2023-12-31 was $0.00.
- ALPHA TEKNOVA, INC. repayments of long-term debt for the quarter ending 2022-12-31 was $0.00.
- ALPHA TEKNOVA, INC. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- ALPHA TEKNOVA, INC. repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. repayments of long-term debt for fiscal 2023 was $10.00M.
- ALPHA TEKNOVA, INC. repayments of long-term debt for fiscal 2022 was $0.00.
- ALPHA TEKNOVA, INC. repayments of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $0.00 10-K · filed 2025-03-07 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $10.00M 10-K · filed 2025-03-07 | ||
| 2023-09-30 | $10.00M 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $0.00 10-K · filed 2024-03-27 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $0.00 10-K · filed 2022-03-18 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $45.00K 10-K · filed 2022-03-18 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $45.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $45.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |